AMO-02 (tideglusib) for the treatment of congenital and childhood onset myotonic dystrophy type 1
Horrigan, J., McMorn, A., Snape, M., Nikolenko, N., Gomes, T., Lochmuller, H.Volume:
28
Language:
english
Journal:
Neuromuscular Disorders
DOI:
10.1016/S0960-8966(18)30330-4
Date:
April, 2018
File:
PDF, 30 KB
english, 2018